The Impact of the COVID-19 Pandemic on China's Manufacturing Sector: A Global Value Chain Perspective.
COVID-19 pandemic
China
GTAP model
GVC reconfiguraiton
manufacturing sector
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2021
2021
Historique:
received:
22
03
2021
accepted:
12
04
2021
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
This paper, based on the notion of Trade in Value Added (TiVA), combines the global trade analysis project (GTAP) model with the value-added model in seeking to simulate and assess the impact of the COVID-19 pandemic on China's manufacturing sector in global value chain (GVC) reconfiguration. The empirical study provides three major results. First, at the macroeconomic level, the pandemic wreaks a negative impact on all the economies, including the U.S., in regard to import & export trade, GDP and social welfare policy. Second, nation-level simulation shows that there's a remarkable disparity across different pandemic scenarios in the level of division of labor and of GVC participation for China and its trade partners. Third, sector-level analysis shows that the impacts of the pandemic include promoting the level of GVC participation and of labor division in China's manufacturing sector (electromechanical equipment and computer goods). This paper also provides policy advice for Chinese government: participation in higher-end GVCs, introduction of further structural reforms and retention of foreign investors, and active responses to GVC reconfiguration and cross-border capital flow.
Identifiants
pubmed: 34055731
doi: 10.3389/fpubh.2021.683821
pmc: PMC8160105
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
683821Informations de copyright
Copyright © 2021 Song, Hao, Hu and Lu.
Déclaration de conflit d'intérêts
YH was employed by the company NPD Information Consulting (Shanghai) Co. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Dev Econ. 2021 Mar 30;:
pubmed: 33821021
Risk Anal. 2017 Jan;37(1):4-19
pubmed: 27214756
Health Policy. 2008 Oct;88(1):110-20
pubmed: 18436332
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):178-184
pubmed: 32391661
J Med Virol. 2020 May;92(5):473-475
pubmed: 32048740
World Dev. 2021 Mar;139:105324
pubmed: 33293754